Leonardo Baiocchi
Overview
Explore the profile of Leonardo Baiocchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
822
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaho J, Kamberi F, Mechili E, Bicaj A, Carni P, Baiocchi L
World J Virol
. 2024 Dec;
13(4):93721.
PMID: 39722761
Background: Hepatitis B virus (HBV) is categorized as one of the smallest enveloped DNA viruses and is the prototypical virus of the Hepatoviridae family. It is usually transmitted through body...
2.
Calvaruso V, Celsa C, Cristoferi L, Scaravaglio M, Smith R, Kaur S, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39674236
Background & Aims: Noninvasive tests (NITs) for ruling-out clinical significant portal hypertension (CSPH) and high-risk varices (HRVs) in patients with primary biliary cholangitis (PBC) and compensated advanced chronic liver disease...
3.
Manzia T, Sensi B, Gentileschi P, Quaranta C, Toti L, Baiocchi L, et al.
Liver Transpl
. 2024 Oct;
PMID: 39451118
In obese patients, metabolic dysfunction-associated steatotic liver disease is becoming a leading etiology of end-stage liver disease and HCC. Simultaneous liver transplantation and sleeve gastrectomy (LT-SG) have been proposed in...
4.
Kondili L, Brancaccio G, Tosti M, Coco B, Quaranta M, Messina V, et al.
Int J Infect Dis
. 2024 May;
146:107115.
PMID: 38801968
Background And Aims: We aimed to characterize the epidemiologic and comorbidities profiles of patients with chronic Hepatitis D (CHD) followed in clinical practice in Italy and explored their interferon (IFN)...
5.
Lenci I, Milana M, Savino L, Signorello A, Baiocchi L
Rev Recent Clin Trials
. 2024 May;
19(4):267-272.
PMID: 38797899
Purpose: SARS-CoV-2 infection has been associated with the impairment of several organs, including the liver. In addition, cases of autoimmune hepatitis have been described in association with COVID-19 disease. According...
6.
De Vincentis A, Ampuero J, Terracciani F, DAmato D, Gerussi A, Cristoferi L, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(10):2062-2074.e11.
PMID: 38782175
Background & Aims: Obeticholic acid (OCA) is the only licensed second-line therapy for primary biliary cholangitis (PBC). With novel therapeutics in advanced development, clinical tools are needed to tailor the...
7.
Angelico R, Sensi B, Toti L, Campanella E, Lenci I, Baiocchi L, et al.
Transplantation
. 2024 May;
108(11):2247-2259.
PMID: 38771123
Background: Liver transplant (LT) recipients often experience adverse effects of immunosuppressive (IS) drugs, especially on metabolic profiles. Selected LT recipients can achieve successful IS withdrawal; however, its effects on metabolic...
8.
Abenavoli L, Gambardella M, Scarlata G, Lenci I, Baiocchi L, Luzza F
Medicina (Kaunas)
. 2024 Apr;
60(4).
PMID: 38674209
The gastrointestinal tract is inhabited by the gut microbiota. The main phyla are Firmicutes and Bacteroidetes. In non-alcoholic fatty liver disease, now renamed metabolic dysfunction-associated fatty liver disease (MAFLD), an...
9.
Kondili L, Zanetto A, Quaranta M, Ferrigno L, Panetta V, Calvaruso V, et al.
United European Gastroenterol J
. 2023 Nov;
12(3):352-363.
PMID: 38032175
Background & Aims: Sustained virological response (SVR) by direct-acting antivirals (DAAs) may reverse the hypercoagulable state of HCV cirrhosis and the portal vein thrombosis (PVT) risk. We evaluated the incidence...
10.
Salpini R, Piermatteo L, Torre G, DAnna S, Khan S, Duca L, et al.
Int J Infect Dis
. 2023 Nov;
138:1-9.
PMID: 37944585
Objectives: Here we investigate Hepatitis D virus (HDV)-prevalence in Italy and its fluctuations over time and we provide an extensive characterization of HDV-infected patients. Methods: The rate of HDV seroprevalence...